Paid Clinical Trials Jacksonville
Discover 705 paid clinical trials in Jacksonville, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Observational StudyPancreatic Cancer Early Detection Consortium
Sponsor:
Arbor Research Collaborative for Health
Location:
Code:
NCT04970056
Conditions
Pancreas Cancer
Pancreas Cyst
Pancreatic Ductal Adenocarcinoma
Genetic Predisposition
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Observational StudyAssessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery Disease
Sponsor:
CirQuest Labs, LLC
Location:
Code:
NCT03551756
Conditions
Heart Failure With Reduced Ejection Fraction
Coronary Artery Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Biomarker Assessment
MPH HCl EREfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD
Sponsor:
Ironshore Pharmaceuticals and Development, Inc
Location:
Code:
NCT06431256
Conditions
Attention Deficit Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 4 - 5
Healthy Volunteers: Not accepted
Interventions
HLD200 methylphenidate hydrochloride capsules
Placebo HLD200 capsules
Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Location:
Code:
NCT06369285
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alisertib
Endocrine therapy
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Dato-DXd & PembrolizumabDatopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
Sponsor:
Daiichi Sankyo
Location:
Code:
NCT05555732
Conditions
Metastatic Non Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Datopotamab Deruxtecan
Pembrolizumab
Pemetrexed
Carboplatin
Cisplatin
GI-102, Pembrolizumab, T-DXdA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Sponsor:
GI Innovation, Inc.
Location:
Code:
NCT05824975
Conditions
Advanced Solid Tumor
Metastatic Solid Tumor
Soft Tissue Sarcoma (STS)
Platinum-resistant Ovarian Cancer (PROC)
Hepatocellular Carcinoma (HCC)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
GI-102 subcutaneous (SC)
GI-102
doxorubicin
paclitaxel
bevacizumab
autoRICRemote Ischemic Conditioning Using the autoRIC
Sponsor:
CellAegis US, Inc.
Location:
Code:
NCT03318575
Conditions
Ischemia-Reperfusion Injury
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
autoRIC
autoRIC Sham
Observational StudyAn INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY to ASSESS the PERFORMANCE of the CORDIO HEARO SYSTEM
Sponsor:
Cordio Medical
Location:
Code:
NCT06378632
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
Hearo App
MMSET InhibitorA Study of an MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma
Sponsor:
K36 Therapeutics, Inc.
Location:
Code:
NCT05651932
Conditions
Multiple Myeloma
Myeloma
Myeloma Multiple
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cohort A1 & A2
Cohort C1 & C2
Cohort D